Skip to content
AIThe Defiant

Isomorphic Labs Raises $5 Billion for AI Drug Design

By The Defiant

Greenoaks and Sequoia co-led the Series C as Isomorphic prepares its first therapeutic programs for clinical trials, with Alphabet investing again.

Read Original Article

More in AI

From the blog